These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 20219081

  • 1. A rapid chemokine response of macrophage inflammatory protein (MIP)-1α, MIP-1β and the regulated on activation, normal T expressed and secreted chemokine is associated with a sustained virological response in the treatment of chronic hepatitis C.
    Florholmen J, Kristiansen MG, Steigen SE, Sørbye SW, Paulssen EJ, Kvamme JM, Konopski Z, Gutteberg T, Goll R.
    Clin Microbiol Infect; 2011 Feb; 17(2):204-9. PubMed ID: 20219081
    [Abstract] [Full Text] [Related]

  • 2. Kinetics of chemokines in acute myocardial infarction.
    Kobusiak-Prokopowicz M, Orzeszko J, Mazur G, Mysiak A, Orda A, Mazurek W.
    Kardiol Pol; 2005 Apr; 62(4):301-14; discussion 315-6. PubMed ID: 15928736
    [Abstract] [Full Text] [Related]

  • 3. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.
    Nischalke HD, Nattermann J, Fischer HP, Sauerbruch T, Spengler U, Dumoulin FL.
    Mediators Inflamm; 2004 Dec; 13(5-6):357-9. PubMed ID: 15770052
    [Abstract] [Full Text] [Related]

  • 4. Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection.
    Montes de Oca Arjona M, Pérez Cano R, Orozco MJ, Martín Aspas A, Guerrero F, Fernández Gutiérrez Del Alamo C, Girón-González JA.
    Clin Microbiol Infect; 2005 Jan; 11(1):57-62. PubMed ID: 15649305
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Cytokine; 2004 Dec 21; 28(6):197-204. PubMed ID: 15566948
    [Abstract] [Full Text] [Related]

  • 6. Lack of good correlation of serum CC-chemokine levels with human immunodeficiency virus-1 disease stage and response to treatment.
    Ye P, Kazanjian P, Kunkel SL, Kirschner DE.
    J Lab Clin Med; 2004 May 21; 143(5):310-9. PubMed ID: 15122175
    [Abstract] [Full Text] [Related]

  • 7. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
    Gonzalez VD, Falconer K, Björkström NK, Blom KG, Weiland O, Ljunggren HG, Alaeus A, Sandberg JK.
    J Immunol; 2009 Nov 15; 183(10):6612-8. PubMed ID: 19846870
    [Abstract] [Full Text] [Related]

  • 8. [Correlation of chemokines and chemokine receptors with clinical features in newly diagnosed systemic lupus erythematosus].
    Tao JH, Li XP, Li XM, Kan M, Zhai ZM, Wang W.
    Zhonghua Yi Xue Za Zhi; 2006 Nov 21; 86(43):3051-4. PubMed ID: 17288835
    [Abstract] [Full Text] [Related]

  • 9. Circulating levels of beta-chemokines in systemic lupus erythematosus.
    Kaneko H, Ogasawara H, Naito T, Akimoto H, Lee S, Hishikawa T, Sekigawa I, Tokano Y, Takasaki Y, Hirose SI, Hashimoto H.
    J Rheumatol; 1999 Mar 21; 26(3):568-73. PubMed ID: 10090164
    [Abstract] [Full Text] [Related]

  • 10. Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection.
    Lichterfeld M, Leifeld L, Nischalke HD, Rockstroh JK, Hess L, Sauerbruch T, Spengler U.
    J Infect Dis; 2002 Jun 15; 185(12):1803-7. PubMed ID: 12085329
    [Abstract] [Full Text] [Related]

  • 11. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
    Zeremski M, Petrovic LM, Talal AH.
    J Viral Hepat; 2007 Oct 15; 14(10):675-87. PubMed ID: 17875002
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
    Rothenbacher D, Müller-Scholze S, Herder C, Koenig W, Kolb H.
    Arterioscler Thromb Vasc Biol; 2006 Jan 15; 26(1):194-9. PubMed ID: 16239601
    [Abstract] [Full Text] [Related]

  • 13. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
    Crane IJ, McKillop-Smith S, Wallace CA, Lamont GR, Forrester JV.
    Invest Ophthalmol Vis Sci; 2001 Jun 15; 42(7):1547-52. PubMed ID: 11381059
    [Abstract] [Full Text] [Related]

  • 14. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
    Vicenzi E, Alfano M, Ghezzi S, Gatti A, Veglia F, Lazzarin A, Sozzani S, Mantovani A, Poli G.
    J Leukoc Biol; 2000 Sep 15; 68(3):405-12. PubMed ID: 10985258
    [Abstract] [Full Text] [Related]

  • 15. Beta-chemokine function in experimental lung ischemia-reperfusion injury.
    Krishnadasan B, Farivar AS, Naidu BV, Woolley SM, Byrne K, Fraga CH, Mulligan MS.
    Ann Thorac Surg; 2004 Mar 15; 77(3):1056-62. PubMed ID: 14992926
    [Abstract] [Full Text] [Related]

  • 16. Association between plasma levels of eotaxin (CCL-11) and treatment response to interferon-alpha and ribavirin in HIV/HCV co-infected patients.
    Vargas A, Berenguer J, Catalán P, Miralles P, López JC, Cosín J, Resino S.
    J Antimicrob Chemother; 2010 Feb 15; 65(2):303-6. PubMed ID: 20016018
    [Abstract] [Full Text] [Related]

  • 17. Concentrations of macrophage inflammatory proteins MIP-1alpha and MIP-1beta and interleukin 8 (il-8) in lyme borreliosis.
    Grygorczuk S, Pancewicz S, Zajkowska J, Kondrusik M, Rwierzbińska R, Hermanowska-Szpakowicz T.
    Infection; 2004 Dec 15; 32(6):350-5. PubMed ID: 15597225
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.